Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Erica Evans, Joseph L. Kim et al.|Cancer Discovery|2018Cited by 392
Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and EvaluationJean-Christophe Harmange, Roger Zanon, Matthew M. Weiss et al.|Journal of Medicinal Chemistry|2008Cited by 70